HBV-Tg mice publications：

1. Stat3 activation-triggered transcriptional networks govern the early stage of HBV-induced hepatic inflammation.

2. RNA‐binding motif protein 24 inhibits HBV replication in vivo.

3. Hepatitis B virus hijacks TSG101 to facilitate egress via multiple vesicle bodies.

4. Co-delivery of Cas9 mRNA and guide RNAs edits hepatitis B virus episomal  and integration DNA in mouse and tree shrew models.

5. Anti-HBV Activities of Polysaccharides from Thais clavigera (Küster) by In Vitro and In Vivo Study.

6. Pathological features of liver inflammation and fibrosis in hepatitis B virus transgenic mice C57BL/6N -Tg(1.28HBV) /Vst.

7. Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9.

8. Engineered extracellular vesicles for delivering functional Cas9/gRNA to eliminate hepatitis B virus cccDNA and integration.

9. Release mechanism and pharmacodynamics of entecavir micro spheres.

10. Single-cell RNA sequencing reveals reduced intercellular adhesion molecule crosstalk between activated hepatic stellate cells and neutrophils alleviating liver fibrosis in hepatitis B virus transgenic mice post menstrual blood-derived mesenchymal stem cell transplantation.